Dafna Capital Management LLC Century Therapeutics, Inc. Transaction History
Dafna Capital Management LLC
- $331 Million
- Q1 2025
A detailed history of Dafna Capital Management LLC transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Dafna Capital Management LLC holds 1,704,232 shares of IPSC stock, worth $988,454. This represents 0.25% of its overall portfolio holdings.
Number of Shares
1,704,232
Previous 1,704,232
-0.0%
Holding current value
$988,454
Previous $1.72 Million
52.47%
% of portfolio
0.25%
Previous 0.47%
Shares
6 transactions
Others Institutions Holding IPSC
# of Institutions
71Shares Held
27.4MCall Options Held
12.1KPut Options Held
0-
Bain Capital Life Sciences Investors, LLC Boston, MA5.41MShares$3.14 Million0.87% of portfolio
-
Casdin Capital, LLC New York, NY3.21MShares$1.86 Million0.18% of portfolio
-
Black Rock Inc. New York, NY2.9MShares$1.68 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY2.5MShares$1.45 Million0.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.38MShares$1.38 Million0.0% of portfolio
About Century Therapeutics, Inc.
- Ticker IPSC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,881,800
- Market Cap $34.2M
- Description
- Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...